Related Experiment Video
Updated: Mar 27, 2026

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Published on: January 13, 2026
Routine Antibiotic Prophylaxis for Totally Implantable Venous Access Device Placement: Meta-Analysis of 2,154
Evan Johnson1, James Babb1, Divya Sridhar1
1Department of Radiology, Center for Biomedical Imaging, NYU Langone Medical Center, 660 First Avenue, New York, NY 10016.
Purpose:
To provide a meta-analysis of currently available literature on the topic of antibiotic prophylaxis for totally implanted venous access device (TIVAD) placement.
Materials And Methods:
A systematic review of MEDLINE/PubMed was performed to identify studies that met Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria reviewing antibiotic prophylaxis in TIVAD placement. Four studies were identified that met criteria. The analysis included 2,154 patients undergoing TIVAD placement; 360 (16.7%) received antibiotic prophylaxis, and 1,794 (83.3%) received no periprocedural antibiotics.
Results:
In the period after TIVAD placement, 27 (1.25%) infections were identified. Of infections, five occurred in the antibiotic prophylaxis group (1.39%), and 22 occurred in the nonprophylaxis group (1.23%) with an odds ratio of 0.84 (CI = 0.29-2.35).
Conclusions:
The odds ratio of infection was 0.85 with antibiotic use but one was contained within the confidence interval suggesting no significant difference in infection rate when antibiotics were used.
Insights
Antibiotic prophylaxis for totally implanted venous access device (TIVAD) placement did not significantly reduce infection rates. This meta-analysis found no statistically significant difference in infections between patients who received antibiotics and those who did not.
Area of Science:
- Medical Research
- Infectious Disease Prevention
- Vascular Access Devices
Background:
- Totally implanted venous access devices (TIVADs) are crucial for long-term therapies.
- Infection is a significant complication associated with TIVAD placement.
- The role of antibiotic prophylaxis in preventing TIVAD-related infections remains debated.
Purpose of the Study:
- To conduct a meta-analysis of existing literature on antibiotic prophylaxis during TIVAD placement.
- To evaluate the efficacy of antibiotic prophylaxis in reducing infection rates following TIVAD insertion.
Main Methods:
- Systematic review of MEDLINE/PubMed adhering to PRISMA guidelines.
- Inclusion of four studies encompassing 2,154 patients undergoing TIVAD placement.
- Comparison of infection rates between patients receiving antibiotic prophylaxis (n=360) and those not receiving it (n=1,794).
Main Results:
- A total of 27 infections (1.25%) were identified post-TIVAD placement.
- Infection rates were 1.39% in the antibiotic prophylaxis group and 1.23% in the nonprophylaxis group.
- The odds ratio for infection was 0.84 (CI = 0.29-2.35), indicating no significant difference.
Conclusions:
- Antibiotic prophylaxis use in TIVAD placement showed an odds ratio of 0.85 for infection.
- The confidence interval included 1, suggesting no statistically significant reduction in infection rates.
- Current evidence does not support routine antibiotic prophylaxis for TIVAD placement to prevent infections.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

